DOPAVISION
Dopavision is a therapeutic company developing a digital therapeutic for myopia. Myopia, or shortsightedness, is a condition where the visual image is focused in front of the retina, instead of on the retina itself, as it should. People with myopia have good near sight vision but poor distance vision. Dopavision is developing a digital therapeutic for myopia which can be seamlessly and invisibly integrated with the use of a smartphone. Myopia is a visual condition that affects on average every t... hird person globally, a share that has increased rapidly during the last two decades. The goal of the Berlin-based startup is to develop a clinically validated therapy for myopia progression in children and adolescents. The technology delivers light stimulation to specific photosensitive cells on the retina which in turn modulate dopamine, a neurotransmitter that is important for the regulation of eye growth. Founded in 2017, Dopavision GmbH is supported by the German government via the โIndustrie-in-Klinikโ program of the BMBF (Federal Ministry of Education and Research) with the amount of โฌ 1.4 million over three years.
DOPAVISION
Social Links:
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2017-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.dopavision.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13.2 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Kvatchii
Kvatchii is developing a truly patient-focused deep health digital platform from ground-up in India.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Dopavision
Seventure Partners
Seventure Partners investment in Series A - Dopavision
Ababax.Health
Ababax.Health investment in Series A - Dopavision
dRx Capital
dRx Capital investment in Series A - Dopavision
Novartis Pharma
Novartis Pharma investment in Series A - Dopavision
Ralf Meister
Ralf Meister investment in Seed Round - Dopavision
Flyinghealth
Flyinghealth investment in Seed Round - Dopavision
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Seed Round - Dopavision
Key Employee Changes
Date | New article |
---|---|
2022-05-25 | Dopavision Appoints Mark S. Wuttke, Ph.D., as Chief Executive Officer |
Official Site Inspections
http://www.dopavision.com
- Host name: wp1.swpress.de
- IP address: 213.133.103.236
- Location: Nuremberg Germany
- Latitude: 49.4475
- Longitude: 11.0683
- Timezone: Europe/Berlin
- Postal: 90409